Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.

about

Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.

Item

http://www.wikidata.org/entity/Q40066358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Adalimumab therapy in a patien ...... aganglioma after chemotherapy.

@en

type

Item

label

Adalimumab therapy in a patien ...... aganglioma after chemotherapy.

@en

prefLabel

Adalimumab therapy in a patien ...... aganglioma after chemotherapy.

@en

P1476

Adalimumab therapy in a patien ...... aganglioma after chemotherapy.

@en

P2093

Eiji Kubota

http://www.w3.org/2001/XMLSchema#string

Hiromi Kataoka

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Sagawa

http://www.w3.org/2001/XMLSchema#string

Keiji Ozeki

http://www.w3.org/2001/XMLSchema#string

Masashi Ando

http://www.w3.org/2001/XMLSchema#string

Satoshi Tanida

http://www.w3.org/2001/XMLSchema#string

Takahito Katano

http://www.w3.org/2001/XMLSchema#string

Takashi Joh

http://www.w3.org/2001/XMLSchema#string

Takaya Shimura

http://www.w3.org/2001/XMLSchema#string

Takeshi Kamiya

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical management of paragangliomas

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Do inflammatory bowel disease therapies cause cancer?

Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota

Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result.

Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.

Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease.

Metastatic pheochromocytoma and paraganglioma.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.

P2888

s12328-017-0726-3

P304

250-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-017-0726-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28271435

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab